Key result
Sustained higher SBP linked to ~11% lower stress myocardial blood flow per 10 mm Hg.
Why the study?
Elevated blood pressure is a major contributor to coronary artery disease, but the impact of life-course blood pressure on later-life myocardial perfusion was unexplored.
Does higher cumulative life-course blood pressure reduce myocardial perfusion measured by cardiovascular magnetic resonance in older adults?
Cohort (n=459)
Does higher cumulative life-course blood pressure reduce myocardial perfusion measured by cardiovascular magnetic resonance in older adults?
Higher life-course blood pressure and steeper age-related increases from early adulthood to older age are independently associated with reduced myocardial perfusion and greater myocardial fibrosis at age 77, underscoring the importance of early and sustained blood pressure control.
Answers are grounded in this paper and cite their sources.
Sustained higher SBP may impair older-age myocardial perfusion; extends life-course BP links to CMR measures but remains hypothesis-generating.
BACKGROUND: Elevated blood pressure (BP) is a major contributor to coronary artery disease. We explored the impact of life-course BP on later-life normalized stress myocardial blood flow (sMBF N ) and myocardial perfusion reserve by cardiovascular magnetic resonance (CMR). METHODS: MyoFit46 prospectively recruited ≈500 National Survey of Health and Development 1946 birth cohort participants, aged ≈77 years, to undergo stress perfusion and late gadolinium enhancement CMR. Systolic (SBPs) and diastolic BPs were recorded at 36, 43, 53, 63, 69, and 77 years. For each participant, the annual rates of BP change (steepness of BP increase) and area under the BP trajectory curve (cumulative life-course BP burden) were derived using mixed-effects models. The associations between BP measures and CMR metrics were tested using generalized linear and additive models, adjusted for antihypertensive use, demographics, lifestyle choices, and comorbidities. Cross-sectional associations between CMR metrics and major adverse cardiovascular events (myocardial infarction, stroke, and heart failure) were also tested. Mediation analyses explored the mechanistic pathways linking life-course BPs, myocardial perfusion, and myocardial fibrosis. RESULTS: Among 459 included MyoFit46 participants, each 10 mm Hg higher SBP at 36 to 69 years was associated with 3% to 6% lower sMBF N by CMR at 77 years. At 43 to 63 years, as SBPs rose from 120 to 140 mm Hg, sMBF N was 18% to 24% lower. Having a sustained higher SBP by 10 mm Hg from 36 to 77 years was associated with 11% (95% CI, 8–14) lower sMBF N at 77 years. Each 1 mm Hg/y steeper SBP rise during age intervals 36 to 43, 43 to 53, 53 to 63, and 63 to 69 years was associated with 2% to 6% lower sMBF N at 77 years, associations not conditional on baseline or final BPs in each age interval. Associations may be clinically relevant as each 1% lower sMBF N was associated with 3% higher odds of major adverse cardiovascular events. sMBF N mediated ≈20% to ≈40% of the associations between life-course SBPs and late gadolinium enhancement at 77 years. Results were similar for diastolic BP, myocardial perfusion reserve, or sMBF (not normalized). CONCLUSIONS: Higher life-course BPs, steeper increases, and greater cumulative BP burden associate with lower myocardial perfusion by CMR at 77 years, which can be linked with higher odds of major adverse cardiovascular events and greater myocardial fibrosis burden. This underscores the importance of early life BP screening and guiding hyperetension treatment based on longitudinal BP trajectories (rather than relying solely on cross-sectional BPs). REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05455125.
No takes yet. Share an insight, caveat, or question.
Topriceanu et al. (2025) conducted a cohort in Elevated blood pressure and reduced myocardial perfusion (n=459). Higher life-course blood pressure trajectories vs. Lower life-course blood pressure trajectories was evaluated on Normalized stress myocardial blood flow (sMBF N) at 77 years (11% lower, 95% CI 8-14). Having a sustained higher systolic blood pressure by 10 mm Hg from 36 to 77 years was associated with an 11% lower normalized stress myocardial blood flow at age 77.
Synapse has enriched 10 related papers. Consider them for comparative context: